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The impact of life tables adjusted for smoking
on the socio-economic difference in net
survival for laryngeal and lung cancer
L Ellis*,1, M P Coleman1 and B Rachet1
1Cancer Research UK Cancer Survival Group, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E
7HT, UK
Background: Net survival is a key measure in cancer control, but estimates for cancers that are strongly associated with smoking
may be biased. General population life tables represent background mortality in net survival, but may not adequately reflect the
higher mortality experienced by smokers.
Methods: Life tables adjusted for smoking were developed, and their impact on net survival and inequalities in net survival for
laryngeal and lung cancers was examined.
Results: The 5-year net survival estimated with smoking-adjusted life tables was consistently higher than the survival estimated
with unadjusted life tables: 7% higher for laryngeal cancer and 1.5% higher for lung cancer. The impact of using smoking-adjusted
life tables was more pronounced in affluent patients; the deprivation gap in 5-year net survival for laryngeal cancer widened by 3%,
from 11% to 14%.
Conclusions: Using smoking-adjusted life tables to estimate net survival has only a small impact on the deprivation gap in survival,
even when inequalities are substantial. Adjusting for the higher, smoking-related background mortality did increase the estimates
of net survival for all deprivation groups, and may be more important when measuring the public health impact of differences or
changes in survival, such as avoidable deaths or crude probabilities of death.
Net survival is a key measure of interest for cancer control. It is
defined as the survival of cancer patients in the hypothetical
situation, where they cannot die from causes other than cancer.
Net survival ‘corrects’ the all-cause survival of a group of cancer
patients by taking into account mortality due to other causes (the
so-called expected or background mortality), that is, the mortality
the patients would experience if they did not have cancer. When
the cause of death is not reliably known for all patients, such as in
population-based cancer registry data, the expected mortality of
the patients is provided by life tables of the general population with
the same socio-demographic characteristics as the cancer patients.
This expected mortality is subtracted from the all-cause mortality
for a group of cancer patients, thus enabling interpretation to focus
on mortality in excess of the background mortality, which is then
considered attributable to the cancer. Because background
mortality is higher among smokers, the use of general life tables,
unadjusted for smoking, may produce biased estimates of survival
for cancers that are strongly associated with smoking. Such
unadjusted life tables will provide under-estimated expected
mortality, leading to overestimation of the excess (cancer-related)
mortality of patients who are smokers (Figure 1). Consequently,
net survival estimated on the basis of these unadjusted life tables
may be an underestimate of the ‘true’ net survival.
This theory was first proposed in 1961 by Ederer, who
constructed approximate life tables for smokers, derived from
mortality data from a cohort study, and tested their impact on
survival estimates. The life tables for smokers made very little
difference to the survival estimates, although this analysis was for
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all cancers combined: a smaller impact would therefore be expected
(Ederer et al, 1961). Ederer’s life tables might have made more
difference to the estimates of survival for cancers that are strongly
associated with smoking, such as cancer of the larynx and lung.
Two recent studies investigated this issue using different methods
in different contexts, and, although they did not generally observe a
strong impact of the use of life tables for smokers on relative
survival estimates, the conclusions may differ according to the type
of cancer (Blakeley et al, 2012; Hinchliffe et al, 2012).
While life tables adjusted for smoking may produce less-biased
estimates of survival overall, they may also affect the known socio-
economic gradient in net survival for some cancers, depending on
whether national or deprivation-specific life tables are used. The
prevalence of smoking in the general population differs between
socio-economic groups: in 2008, the prevalence of smoking in
deprived groups (routine and manual socio-economic category)
was 29%, compared to 14% in the most affluent (managerial and
professional socio-economic category) (Office for National
Statistics, 2010). The prevalence of smoking in the general
population must be compared to that observed in patients
diagnosed with laryngeal or lung cancer, the majority of whom
are assumed to be smokers. The differential in smoking prevalence
between the general population and cancer patients will therefore
be larger in the more affluent groups than in the more deprived.
The use of smoking-adjusted life tables will increase the estimates
of net survival for all deprivation groups, but more so for the most
affluent patients. This would result in a steeper deprivation
gradient in net survival between affluent and deprived patients.
This paper describes the methodology used in the development of
life tables adjusted for smoking, and the extent of their impact on
net survival estimates and inequalities in survival for laryngeal and
lung cancers.
MATERIALS AND METHODS
A life table is simply a set of age- and sex-specific mortality rates for
a specified population, and is constructed from the number of
deaths and the population counts. In order to produce a life table
that is specific for smokers directly from the raw data, both the
number of deaths and the populations would need to be available by
smoking status. These data are not available nationally in the UK.
An alternative method was developed, which involved adjusting
existing national and deprivation-specific life tables (Cancer
Research UK Cancer Survival Group, 2009) with published age-
and sex-specific estimates of smoking-related mortality. It was not
possible, or indeed necessary, to make any adjustment in the
younger age groups, as both the prevalence of smoking and the
hazard rate ratio of death associated with it are low.
Many studies have been published on the effect of smoking on all-
cause mortality in a variety of populations and age groups
(Carstensen et al, 1987; Floderus et al, 1988; LaCroix et al, 1991;
Tverdal et al, 1993; Doll et al, 1994; Illing and Kaiserman, 1995; Thun
et al, 1995; Prescott et al, 1998; Jacobs et al, 1999; Qiao et al, 2000;
Nilsson et al, 2001; Ezzati and Lopez, 2003; Doll et al, 2004; Rodu
and Cole, 2004; Blakely and Wilson, 2005; Zorrilla-Torras et al, 2005;
Jha et al, 2006; Vollset et al, 2006; Kenfield et al, 2008; Woloshin et al,
2008; Gruer et al, 2009). The direction of the relative measures
reported was consistent, although the magnitude of the hazard rate
ratios differed, depending on whether the studies examined light,
moderate or heavy smokers, or all smokers combined. Only a few
studies have directly estimated the effect of smoking on all-cause
mortality in people from different deprivation groups. Therefore, a
number of assumptions need to be made when adjusting life tables
for smoking: (1) about the effect of deprivation on mortality in
smokers, and (2) about the magnitude of the hazard ratio.
Background mortality in the general population is known to
differ by deprivation, and deprivation-specific life tables are
required to produce less biased estimates of the deprivation gap
in net survival. In the first scenario (S1), we consider that the
higher mortality among smokers differs by deprivation group, to
the same degree as in the general population. Under S1, a
deprivation-specific life table was produced, taking into account
the different prevalence of smoking in each deprivation group. In
contrast, the second scenario (S2) assumes that in smokers this
socio-economic gradient in background mortality does not exist.
Under S2, a national life table was produced, adjusted for the
higher background mortality (and hence lower expected survival)
among smokers, but with no deprivation gradient. Within each
scenario outlined above, a range of adjustments was explored,
based on the lowest, average and highest hazard ratios reported in
the literature (Table 1). The adjustments are termed as A1 (lowest
level of adjustment), A2 (average) and A3 (highest).
The hazard rate ratios obtained from the literature were largely
from cohort studies, and hence were for smokers compared to
non-smokers, rather than smokers compared to the general
population. The following formulae were applied to derive the
all-cause mortality rates in smokers and non-smokers, taking into
account the prevalence of smoking for each sex, age and (where
appropriate) deprivation group:
For each sex and age group:
R0 ¼ R1= P0þRRP1ð Þ
R1 ¼ R1= P0=RRþP1ð Þ
where R0 is the all-cause mortality rate in non-smokers, R1 is the
all-cause mortality rate in smokers, R is the all-cause mortality rate
in the general population (from the unadjusted life table), P0 is
the proportion of non-smokers in the general population, P1 is the
proportion of smokers in the general population, and RR is the
hazard rate ratio of all-cause mortality between smokers and
non-smokers.
The adjustments were applied to the age- and sex-specific
mortality rates in England in 2001, according to the assumptions
described above. To smooth these rates, we employed the flexible
Poisson model we use to build our national and deprivation-
specific life tables: for each sex, we model the main effects of age
and, for the specific life tables, the effect modification between age
and deprivation, using restricted cubic spline functions.
The impact of smoking-adjusted life tables on estimates of net
survival and the deprivation gap in survival was investigated, and
compared to net survival estimated using non-adjusted national and
deprivation-specific life tables. The adjusted life tables represent the
age-, sex- and deprivation-specific background mortality of smokers
As in the general
population 
Total 
(all-cause)
mortality  
Excess
(cancer-related)
mortality  
Expected
mortality 
Expected mortality
Proportion of smokers among cancer
patients 
Majority of 
smokers
Excess
(cancer-related)
mortality  
Figure 1. Partition of the total (all-cause) mortality of a group of cancer
patients into background (expected) mortality and excess (cancer-
related) mortality among the general population and among smokers.
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in 2001. The unadjusted life tables represent the background
mortality of the general population in 2001. One- and five-year net
survivals were estimated for each sex and deprivation group for
patients diagnosed with laryngeal or lung cancer in England during
2001–2005 and followed up to the end of 2009. The records were
provided by the population-based National Cancer Registry of
England, based at the Office for National Statistics. The data used for
this study consisted of 86 289 male and 58 917 female lung cancer
patients, and 7037 male and 1484 female laryngeal cancer patients.
Net survival was estimated using the non-parametric estimator
described by Perme et al (2012). This estimator corrects the Ederer-
II relative survival ratio in order to account for the informative
censoring associated with risk factors such as age, that is, the higher
likelihood that older patients will die of other causes than their
cancer (Ederer et al, 1961). The fitted deprivation gap in survival
between the most affluent and most deprived groups was estimated
using variance-weighted linear regression.
Since the cancer registry data do not contain any information on
patients’ smoking history, we were not able to categorise patients
according to their smoking status. However, it has been estimated that
at least 85% of laryngeal cancers and 90% of lung cancers are
attributable to tobacco smoking in the UK (Anantharaman et al,
2011; Parkin, 2011). Therefore, for the purposes of these analyses, all
laryngeal and lung cancer patients were assumed to have been
smokers. Given the strength of the evidence for tobacco smoking as
the primary risk factor for both cancers, this is a plausible assumption.
RESULTS
Net survival estimates for laryngeal and lung cancer using the
smoking-adjusted life tables (either national or deprivation-specific)
were consistently higher than survival estimated using the
corresponding unadjusted life tables. The magnitude of the
impact of smoking adjustment differed by cancer, sex and, to
some extent, deprivation group.
Laryngeal cancer
Scenario 1 – Deprivation-specific life tables adjusted for smoking.
In scenario 1, the impact on net survival estimates of adjusting the
deprivation-specific life table for smoking was most pronounced
for men with laryngeal cancer. One-year survival was 3.7% higher
and five-year survival was 7.2% higher when smoking-adjusted
deprivation-specific life tables (highest level of adjustment, A3)
were used instead of the unadjusted deprivation-specific life table.
Among women with laryngeal cancer, 1-year survival was 0.9%
higher and 5-year survival 1.7% higher when smoking-adjusted life
tables were used (Table 2). The impact of using smoking-adjusted
life tables (S1) on net survival estimates was slightly more
pronounced in the affluent groups, and, among men, the
deprivation gap in survival widened by 1.6% at 5 years (Table 2).
Scenario 2 – National life tables adjusted for smoking. In
scenario 2, the impact on net survival estimates of adjusting the
national life table for smoking was similar to that under scenario 1.
In men, 1-year survival for laryngeal cancer was 3.5% higher and 5-
year survival was 6.9% higher when national smoking-adjusted life
tables (S2) were used instead of the unadjusted national life table.
In women with laryngeal cancer, survival estimates were 0.9%
higher at 1 year and 1.6% higher at 5 years (Table 3).
In women with laryngeal cancer, the impact of the national
smoking-adjusted life tables (S2) on survival estimates was similar
for all deprivation groups, so there was very little change to the
deprivation gap in survival at 1 or 5 years (Table 3). In men with
Table 1. Hazard rate ratios of all-cause mortality in smokers compared to non-smokers, and prevalence of smoking in England in 2001, by sex, age and
deprivation group
Hazard rate ratio (RR)
Age
A1 (lowest
adjustment)
A2 (average
adjustment)
A3 (highest
adjustment)
Prevalence of
smoking (P1)
Prevalence of
smoking (affluent)
Prevalence of
smoking (deprived)
Men
35–39 1.8 2.8 3.9 0.31 0.22 0.37
40–44 1.8 2.8 3.9 0.31 0.22 0.37
45–49 2 2.8 3.7 0.31 0.22 0.37
50–54 2.1 2.9 3.7 0.26 0.18 0.31
55–59 2.1 2.5 3.0 0.26 0.18 0.31
60–64 2.1 2.5 3.0 0.16 0.11 0.19
65–69 1.9 2.4 3.0 0.16 0.11 0.19
70–74 1.8 2.3 2.8 0.16 0.11 0.19
75þ 1.5 2.1 2.8 0.16 0.11 0.19
Women
35–39 1 1 1 0.31 0.22 0.37
40–44 1.4 2.1 2.8 0.28 0.20 0.34
45–49 1.8 2.3 2.8 0.28 0.20 0.34
50–54 1.9 2.3 2.8 0.25 0.18 0.30
55–59 2 2.2 2.5 0.25 0.18 0.30
60–64 2 2.2 2.5 0.17 0.12 0.20
65–69 1.8 1.9 2.1 0.17 0.12 0.20
70–74 1.6 1.8 2.1 0.17 0.12 0.20
75þ 1.4 1.4 1.4 0.17 0.12 0.20
Under scenario 2 (S2), a national life table was adjusted taking into account the prevalence of smoking in the general population. Under scenario 1 (S1), the prevalence of smoking in each
deprivation category of the general population is also taken into account.
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laryngeal cancer, the increase in survival when using the smoking-
adjusted life tables was again larger for the affluent groups, and so
the deprivation gap in survival widened, by 1.5% at 1 year (from
 8.5% to  10.0%) and by 3.5% at 5 years (from  11.2% to
 14.7%).
Lung cancer
Scenario 1 – Deprivation-specific life tables adjusted for smoking.
Using smoking-adjusted life tables (both national and deprivation-
specific) had a much smaller impact on net survival estimates for
lung cancer than for laryngeal cancer. In men, 1-year survival was
1.4% higher and 5-year survival was 1.5% higher when smoking-
adjusted deprivation-specific life tables were used (S1) instead of
the unadjusted deprivation-specific life table. In women, there was
very little change to the survival estimates when deprivation-
specific life tables adjusted for smoking (S1) were used (Table 4).
The impact on net survival estimates of the smoking-adjusted
life tables was the same for all deprivation groups, so there was
no change in the deprivation gap in survival for lung cancer for
either sex.
Scenario 2 – National life tables adjusted for smoking. Net
survival for lung cancer estimated with national smoking-adjusted
life tables (under scenario 2) was very similar to survival estimated
using smoking-adjusted deprivation-specific life tables (S1).
Among men, both 1- and 5-year net survival were 1.4% higher
when national smoking-adjusted life tables (S1) were used instead
of the unadjusted national life table (Table 5). In women with lung
cancer, survival increased by less than 1% at both 1 and 5 years.
This probably reflects the lower hazard rate ratios of all-cause
mortality associated with smoking among women.
The impact of adjusting national life tables for smoking (S2) on
the deprivation gap in survival for lung cancer was very small
(o1%) for both men and women. This is because the difference in
survival between affluent and deprived patients with lung cancer is
itself very small.
DISCUSSION
Smoking is the predominant cause of cancers of the larynx and
lung, and is a significant cause of mortality in its own right.
Estimates of net survival reflect the survival of the cancer patients
adjusted for the background mortality in the general population.
The background mortality in people who smoke, however, is
considerably higher than in the general population, and the
majority of laryngeal and lung cancer patients are expected to have
been smokers.
The combination of the predominant aetiological factors having
an unequal influence on overall mortality calls into question the
use of standard life tables in the conventional approach to the
estimation of net survival for cancers strongly related to smoking.
Table 2. One- and five-year net survival, and deprivation gap in survival for laryngeal cancer (England 2001–2005) using deprivation-specific unadjusted
and deprivation-specific smoking-adjusted life tables, by sex
One-year net survival Five-year net survival
Level of smoking adjustmentb Level of smoking adjustmentb
Deprivation
group Unadjusteda
Lowest
(A1)
Average
(A2)
Highest
(A3)
Maximum
differencec Unadjusteda
Lowest
(A1)
Average
(A2)
Highest
(A3)
Maximum
differencec
Men
Overall 84.3 85.7 86.8 87.9 3.7 75.4 78.2 80.3 82.6 7.2
Most affluent 1 88.9 90.3 91.6 92.9 4.0 79.8 82.5 85.0 87.8 8.0
2 87.1 88.5 89.7 90.9 3.8 80.4 83.2 85.6 88.2 7.8
3 84.4 85.8 87.0 88.1 3.8 75.7 78.5 80.8 83.2 7.5
4 82.2 83.6 84.7 85.7 3.4 72.9 75.5 77.5 79.6 6.7
Most deprived 5 82.1 83.6 84.6 85.5 3.4 72.5 75.3 77.2 79.1 6.6
Women
Overall 78.2 79.0 79.1 79.2 0.9 69.7 71.1 71.2 71.4 1.7
Most affluent 1 79.0 79.8 79.8 79.9 0.9 69.8 71.1 71.2 71.3 1.5
2 82.1 82.8 82.9 83.0 0.9 71.7 72.8 73.0 73.1 1.5
3 77.6 78.4 78.5 78.6 1.0 69.3 70.7 70.8 71.0 1.7
4 79.2 79.9 80.0 80.1 0.9 71.4 72.8 72.9 73.0 1.7
Most deprived 5 76.0 76.8 76.8 76.9 1.0 67.8 69.2 69.4 69.6 1.8
Fitted deprivation gap in 1-year net survival Fitted deprivation gap in 5-year net survival
Level of smoking adjustmentb Level of smoking adjustmentb
Unadjusteda
Lowest
(A1)
Average
(A2)
Highest
(A3)
Maximum
differenced Unadjusteda
Lowest
(A1)
Average
(A2)
Highest
(A3)
Maximum
differenced
Men –7.1 –7.1 –7.4 –7.8 0.6 –8.8 –8.8 –9.4 –10.4 1.6
Women –4.6 –4.6 –4.5 –4.5 –0.1 –2.7 –2.5 –2.4 –2.4 –0.3
aDeprivation-specific life table for England 2001.
bSmoking-adjusted life tables based on a range of hazard rate ratios from the literature (see text and Table 1).
cDifference between net survival estimated with the unadjusted deprivation-specific life table, and the net survival estimated using the smoking-adjusted (A3) deprivation-specific life table.
dDifference between the deprivation gap in net survival estimated with unadjusted and smoking-adjusted (A3) life tables.
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This is because the higher background mortality in smokers may
not be adequately reflected in general population life tables.
We developed life tables adjusted for smoking, in order to
examine the effect of the higher all-cause mortality among
smokers on overall estimates of net survival for laryngeal and
lung cancer, as well as on the deprivation gap in survival for those
cancers.
The impact of adjusting life tables for smoking on net survival
estimates for laryngeal and lung cancer (for all deprivation groups
combined) was very similar whether using deprivation-specific
(S1) or national (S2) life tables. The largest impact was among men
diagnosed with laryngeal cancer, where the use of unadjusted life
tables under-estimated net survival by up to 4% at 1 year since
diagnosis, and up to 7% at 5 years since diagnosis. Among patients
diagnosed with lung cancer, the impact of adjusting life tables for
smoking on net survival estimates was negligible.
The estimation of the deprivation gap in survival (the fitted
difference in survival between the most affluent and most deprived
groups) was dependent on the assumptions made regarding the
deprivation gradient in background mortality. As expected, using a
national life table to estimate net survival resulted in the widest
deprivation gap, because the known differences in background
mortality by deprivation in the general population are not
accounted for. However, if the assumption that all-cause mortality
among smokers is identical, regardless of deprivation, is true, the
use of a national life table in this instance may be appropriate. The
deprivation gradient in all-cause mortality in the general popula-
tion is undoubtedly due, in part, to differences in the prevalence of
smoking between deprivation groups: estimates of the contribution
of smoking to inequalities in mortality vary between 20 and 60%
(Blakely and Wilson, 2005; van Rossum et al, 2005; Jha et al, 2006).
It is, however, implausible that smoking is the only cause of this
deprivation gradient, since this ignores other major social
determinants of health inequalities, such as social conditions,
neighbourhood deprivation and unemployment (Blakely and
Wilson, 2006; Marmot, 2006). The use of deprivation-specific life
tables produced a smaller deprivation gap in survival, although for
laryngeal cancer the gap remained substantial. There is very little
difference in survival between affluent and deprived lung cancer
patients, because the prognosis is so poor, so the deprivation gap in
survival is very small, regardless of the life tables used.
Compared to using an unadjusted national or deprivation-
specific life table, adjusting life tables for smoking in order to
estimate net survival tended to increase the deprivation gap for
cancers where inequalities in survival exist. Substantial inequalities
in survival exist for laryngeal cancer in men, but not in women,
among whom no impact of the use of various life tables was
observed.
These results raise several questions. First, it is possible that
deprivation-specific life tables already take account of the
differences in smoking prevalence, and hence the differences in
all-cause mortality due to smoking, across deprivation groups. It
Table 3. One- and five-year net survival, and deprivation gap in survival for laryngeal cancer (England 2001–2005) using national unadjusted and national
smoking-adjusted life tables, by sex
One-year net survival Five-year net survival
Level of smoking adjustmentb Level of smoking adjustmentb
Deprivation
group Unadjusteda
Lowest
(A1)
Average
(A2)
Highest
(A3)
Maximum
differencec Unadjusteda
Lowest
(A1)
Average
(A2)
Highest
(A3)
Maximum
differencec
Men
Overall 84.1 85.5 86.6 87.7 3.5 75.2 77.8 79.9 82.1 6.9
Most affluent 1 89.5 91.2 92.5 93.8 4.3 80.9 84.1 86.7 89.5 8.6
2 87.4 89.0 90.2 91.4 4.0 81.1 84.1 86.6 89.1 8.1
3 84.4 85.9 87.1 88.3 3.8 75.8 78.7 81.0 83.4 7.6
4 81.9 83.2 84.2 85.2 3.2 72.4 74.8 76.7 78.6 6.2
Most deprived 5 81.4 82.5 83.4 84.2 2.8 71.2 73.3 74.9 76.5 5.3
Women
Overall 78.1 78.9 78.9 79.0 0.9 69.5 70.8 70.9 71.1 1.6
Most affluent 1 79.2 80.0 80.1 80.2 0.9 70.3 71.7 71.8 71.9 1.7
2 82.3 83.0 83.1 83.2 0.9 72.0 73.3 73.4 73.6 1.6
3 77.7 78.5 78.5 78.6 1.0 69.3 70.7 70.9 71.0 1.7
4 79.1 79.8 79.8 79.9 0.9 71.1 72.5 72.6 72.7 1.6
Most deprived 5 75.6 76.3 76.3 76.4 0.8 67.1 68.4 68.5 68.6 1.5
Fitted deprivation gap in 1-year net survival Fitted deprivation gap in 5-year net survival
Level of smoking adjustmentb Level of smoking adjustmentb
Unadjusteda
Lowest
(A1)
Average
(A2)
Highest
(A3)
Maximum
differenced Unadjusteda
Lowest
(A1)
Average
(A2)
Highest
(A3)
Maximum
differenced
Men –8.5 –9.0 –9.5 –10.0 1.5 –11.2 –12.3 –13.5 –14.7 3.5
Women –5.3 –5.4 –5.4 –5.4 0.1 –3.9 –4.1 –4.1 –4.1 0.2
aNational life table for England 2001.
bSmoking-adjusted life tables based on a range of hazard rate ratios from the literature (see text and Table 1).
cDifference between net survival estimated with the unadjusted national life table, and the net survival estimated using the smoking-adjusted national life table (A3).
dDifference between the deprivation gap in net survival estimated with unadjusted and smoking-adjusted life tables (A3).
Smoking-adjusted life tables and cancer survival BRITISH JOURNAL OF CANCER
www.bjcancer.com |DOI:10.1038/bjc.2014.217 199
could therefore be argued that further adjustment to deprivation-
specific life tables for the higher background mortality among
smokers is not necessary. However, net survival for each of
deprivation groups is clearly under-estimated when using unad-
justed life tables.
Second, the method of constructing life tables for smokers
presented here is not without its limitations. The lack of mortality
and population data by smoking status meant that a life table could
not be constructed directly from the raw data. Instead, crude
adjustments were made to existing life tables. While the
adjustments were made on the basis of published rate ratios, there
is still margin for error. Studies that have sought to construct life
tables for smokers directly from raw data are limited. One of the
few countries that collect data on smoking at a population level is
New Zealand, where it has been included in the census since 1996.
The New Zealand census is linked to population mortality data,
thus allowing life tables for smokers to be constructed directly from
the raw data. A recent study suggests that the use of non-smoking-
specific life tables could under-estimate the relative survival for
bladder cancer in New Zealand by 10–25% (Blakeley et al, 2012).
A more modest effect was found for lung cancer. One study in
Finland constructed life tables for smokers using a similar method
to that presented here, but found that their use made little impact
on estimates of relative survival for lung cancer compared to
general population life tables (Hinchliffe et al, 2012). These
findings replicate our own, and are not unexpected, because of the
poor prognosis of lung cancer. Neither of these two studies directly
examined the impact of using life tables for smokers on socio-
economic inequalities in cancer survival.
Our adjusted life tables consisted of the overall mortality
associated with tobacco smoking, that is, including mortality from
lung cancer. In theory, the mortality from lung cancer should have
been removed during the building of the life tables adjusted for
smoking. Indeed, cumulative lung cancer mortality among smokers
increases with age and is not negligible in the elderly. However, we
did not account for lung cancer mortality in our life tables because
this component of age-specific mortality rates remains small. In
addition, the range of estimates in the literature of age-specific lung
cancer mortality rates attributable to tobacco smoking is quite
wide: this would have increased the complexity of our scenarios
without adding much insight.
We assumed that all laryngeal and lung cancer patients are or
have been smokers, instead of 85% and 90%, respectively
(Anantharaman et al, 2011; Parkin, 2011), but further analyses
with these proportions showed little or no impact on the survival
estimates (results not shown).
Notwithstanding the limitations of the method, the findings
presented here show that using life tables that are adjusted for the
higher background mortality among smokers in the estimation of
net survival only has a small impact on the deprivation gap in
survival, even when inequalities are substantial (laryngeal cancer in
men) (Rachet et al, 2008). Net survival is thus a robust and
appropriate method for measuring inequalities in cancer-related
survival, even for cancers that are strongly associated with
Table 4. One- and five-year net survival, and deprivation gap in survival for lung cancer (England 2001–2005) using deprivation-specific unadjusted and
deprivation-specific smoking-adjusted life tables, by sex
One-year net survival Five-year net survival
Level of smoking adjustmentb Level of smoking adjustmentb
Deprivation
group Unadjusteda
Lowest
(A1)
Average
(A2)
Highest
(A3)
Maximum
differencec Unadjusteda
Lowest
(A1)
Average
(A2)
Highest
(A3)
Maximum
differencec
Men
Overall 26.3 26.8 27.3 27.7 1.4 13.6 14.1 14.6 15.1 1.5
Most affluent 1 27.8 28.3 28.7 29.1 1.4 14.6 15.1 15.6 16.0 1.4
2 26.0 26.6 27.0 27.4 1.4 13.4 13.9 14.4 14.9 1.5
3 26.6 27.2 27.6 28.0 1.4 13.8 14.3 14.8 15.3 1.5
4 26.0 26.5 27.0 27.4 1.4 13.1 13.7 14.1 14.5 1.4
Most deprived 5 25.7 26.3 26.7 27.1 1.5 13.4 14.1 14.6 15.1 1.6
Women
Overall 29.0 29.3 29.3 29.3 0.4 15.8 16.2 16.2 16.2 0.4
Most affluent 1 31.9 32.2 32.2 32.2 0.4 17.4 17.7 17.7 17.8 0.4
2 29.2 29.5 29.5 29.6 0.4 16.6 16.9 16.9 17.0 0.4
3 29.8 30.2 30.2 30.2 0.4 16.1 16.4 16.4 16.5 0.4
4 27.4 27.7 27.7 27.7 0.4 14.9 15.3 15.3 15.3 0.4
Most deprived 5 28.2 28.6 28.6 28.7 0.4 15.3 15.6 15.7 15.7 0.4
Fitted deprivation gap in 1-year net survival Fitted deprivation gap in 5-year net survival
Level of smoking adjustmentb Level of smoking adjustmentb
Unadjusteda
Lowest
(A1)
Average
(A2)
Highest
(A3)
Maximum
differenced Unadjusteda
Lowest
(A1)
Average
(A2)
Highest
(A3)
Maximum
differenced
Men  1.6 1.5  1.5 1.5  0.1 0.9  0.8 0.8  0.8  0.1
Women  3.3 3.3  3.3 3.3 0.0 2.2  2.2 2.2  2.2 0.0
aDeprivation-specific life table for England 2001.
bSmoking-adjusted life tables based on a range of hazard rate ratios from the literature (see text and Table 1).
cDifference between net survival estimated with the unadjusted deprivation-specific life table, and the net survival estimated using the smoking-adjusted deprivation-specific life table (A3).
dDifference between the deprivation gap in net survival estimated with unadjusted and smoking-adjusted life tables (A3).
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smoking. However, adjusting for the higher, smoking-related
background mortality in the life tables did increase the estimates of
net survival in all deprivation groups for good-prognosis cancers
such as larynx. We can therefore conclude that life tables adjusted
for smoking are not crucial for comparing net survival between
populations, but may be more important for measuring the public
health impact of differences and changes in survival, such as
avoidable deaths (Abdel-Rahman et al, 2009; Ellis et al, 2012) or
crude probabilities of death (Cronin and Feuer, 2000; Lambert
et al, 2010).
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